当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 现金流量表

翰宇药业

(300199)

  

流通市值:155.81亿  总市值:184.69亿
流通股本:7.45亿   总股本:8.83亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金305,085,821.46902,928,792.67641,389,780.62467,365,876.09
  收到的税费返还1,245,829.7435,987,675.7424,529,820.1722,231,763.89
  收到其他与经营活动有关的现金2,691,226.2828,455,561.78133,946,814.9131,203,653.45
  经营活动现金流入小计309,022,877.48967,372,030.19799,866,415.7520,801,293.43
  购买商品、接受劳务支付的现金120,441,679.82299,867,230.65209,603,314.33153,272,721.61
  支付给职工以及为职工支付的现金66,105,478.99187,107,281.08142,466,609.1899,381,894.53
  支付的各项税费15,160,750.8842,284,360.8629,890,438.9921,371,195.35
  支付其他与经营活动有关的现金36,883,675.94204,209,649.32147,206,878.0189,630,913.64
  经营活动现金流出小计238,591,585.63733,468,521.91529,167,240.51363,656,725.13
  经营活动产生的现金流量净额70,431,291.85233,903,508.28270,699,175.19157,144,568.3
二、投资活动产生的现金流量:
  收回投资收到的现金-2,549,989.212,558,316.432,565,285.57
  取得投资收益收到的现金-3,288,131.023,288,131.021
  处置固定资产、无形资产和其他长期资产收回的现金净额310,000430,510478,9908,690
  处置子公司及其他营业单位收到的现金净额-1,854,988.231,454,988.231,454,988.23
  投资活动现金流入小计310,0008,123,618.467,780,425.684,028,964.8
  购建固定资产、无形资产和其他长期资产支付的现金77,327,936.48234,353,262.95172,829,608.8177,225,384.21
  投资支付的现金5,500,000442,850442,850442,850
  投资活动现金流出小计82,827,936.48234,796,112.95173,272,458.8177,668,234.21
  投资活动产生的现金流量净额-82,517,936.48-226,672,494.49-165,492,033.13-73,639,269.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金-100,000100,000-
  其中:子公司吸收少数股东投资收到的现金-100,000--
  取得借款收到的现金581,982,817.481,577,752,645.791,008,500,971.04717,157,320
  收到其他与筹资活动有关的现金328,182,803.62250,214,172.2398,500,00036,000,000
  筹资活动现金流入小计910,165,621.11,828,066,818.021,107,100,971.04753,157,320
  偿还债务支付的现金608,704,153.221,637,444,452.361,036,925,075.14490,600,694.34
  分配股利、利润或偿付利息支付的现金22,684,987.7394,837,492.4559,182,309.8740,531,500.05
  支付其他与筹资活动有关的现金254,064,525.08119,747,239.0493,662,382.0530,007,562.14
  筹资活动现金流出小计885,453,666.031,852,029,183.851,189,769,767.06561,139,756.53
  筹资活动产生的现金流量净额24,711,955.07-23,962,365.83-82,668,796.02192,017,563.47
四、汇率变动对现金及现金等价物的影响-1,487,542.241,481,256.881,935,223.651,822,042.82
五、现金及现金等价物净增加额11,137,768.2-15,250,095.1624,473,569.69277,344,905.18
  加:期初现金及现金等价物余额77,282,74892,532,843.1692,532,843.1692,532,843.16
  期末现金及现金等价物余额88,420,516.277,282,748117,006,412.85369,877,748.34
补充资料:
  净利润-34,026,010.77-144,519,356.92
  资产减值准备-31,252,039.51-1,411,875.22
  固定资产和投资性房地产折旧-104,665,002.81-52,629,674.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-104,665,002.81-52,629,674.34
  无形资产摊销-27,258,873.69-13,796,065.89
  长期待摊费用摊销-6,291,055.72-2,977,821.04
  处置固定资产、无形资产和其他长期资产的损失--617,186.97--552,485.01
  固定资产报废损失-33,093.64-8,923.37
  公允价值变动损失--153,724.57--215,783.62
  财务费用-98,880,040.88-53,099,662.24
  投资损失--1,346,384.37--936,950.62
  递延所得税-8,449,263.09-5,309,420.83
  其中:递延所得税资产减少-1,885,604.23-2,520,469.81
    递延所得税负债增加-6,563,658.86-2,788,951.02
  存货的减少--35,968,856.85--17,596,681.08
  经营性应收项目的减少--49,509,012.22--59,001,749.93
  经营性应付项目的增加-2,253,971.57--40,999,140.66
  现金的期末余额-77,282,748-369,877,748.34
  减:现金的期初余额-92,532,843.16-92,532,843.16
  现金及现金等价物的净增加额--15,250,095.16-277,344,905.18
公告日期2026-04-292026-04-292025-10-302025-08-22
审计意见(境内)标准无保留意见
TOP↑